Reassessment of Twelve Traditional Paradigms Concerning the Diagnosis, Prevalence, Morbidity and Mortality of Rheumatoid Arthritis

References

• Kelley W N, Harris E D, Ruddy S, Sledge C B. Textbook of Rheumatology. Second edition. WB Saunders Co, Philadelphia 1985; 979
   Google Scholar
• McCarty O J. Arthritis and Allied Conditions: A Textbook of Rheumatology. Tenth edition. Lea & Febiger, Philadelphia 1985; 675
   Google Scholar
• Paulus H E, Furst D E, Dromgoole S H. Drugs for Rheumatic Disease. Churchill Livingstone, New York 1987; 203–26
   Google Scholar
• Bunch T W, O'Dufly T D. Disease-modifying drugs for progressive rheumatoid arthritis. Mayo Clin Proc 1980; 55: 161–79
   PubMed Web of Science ®Google Scholar
• Kirwan J R, Currey H LE. Rheumatoid arthritis–disease modifying drugs. Clin Rheum Dis 1983; 9: 581–600
   PubMedGoogle Scholar
• Kelley W N, Harris E D, Ruddy S, Sledge C B. Textbook of Rheumatology. Second edition. WB Saunders Co, Philadelphia 1985; 987
   Google Scholar
• Iannuzzi L, Dawson N, Zein N, Kushner I. Does drug therapy slow radiographic deterioration in rheumatoid arthritis?. N Eng J Med 1983; 309: 1023–8
   PubMed Web of Science ®Google Scholar
• Scott D L, Grindulis K A, Struthers G R, Coulton B L, Popert A J, Bacon P A. Progression of radiological changes in rheumatoid arthritis. Ann Rheum Dis 1984; 43: 8–17
   PubMed Web of Science ®Google Scholar
• Fuchs H A, Kaye J J, Callahan L F, Nance E P, Pincus T. Evidence of significant radiographic damage in rheumatoid arthritis within the first two years of disease. J Rheumatol 1989; 16: 585–91
   PubMed Web of Science ®Google Scholar
• Pincus T, Callahan L F, Sale W G, Brooks A L, Payne L E, Vaughn W K. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years. Arthritis Rheum 1984; 27: 864–72
   PubMed Web of Science ®Google Scholar
• Sherrer Y S, Bloch D A, Mitchell D M, Young D Y. The development of disability in rheumatoid arthritis. Arthritis Rheum 1986; 29: 494–500
   PubMed Web of Science ®Google Scholar
• Scott D L, Coulton B L, Symmons D PM, Popert A J. Long-term outcome of treating rheumatoid arthritis: results after 20years. Lancet 1987; 1108–11
   PubMedGoogle Scholar
• Yelin E H, Meenan R F, Nevitt M, Epstein V W. Work disability in rheumatoid arthritis: Effects of disease, social and work factors. Ann Intern Med 1980; 93: 551–6
   PubMed Web of Science ®Google Scholar
• Meenan R F, Yelin E H, Nevitt M, Epstein W V. The impact of chronic disease: A sociomedical profile of rheumatoid arthritis. Arthritis Rheum 1981; 24: 544–9
   PubMed Web of Science ®Google Scholar
• Pincus T, Callahan L F. Taking mortality in rheumatoid arthritis seriousfy predictive markers, socioeconomic status and comorbidity. Editorial, J Rheumatol 1986; 13: 841–5
   PubMed Web of Science ®Google Scholar
• Mitchell D M, Spitz P W, Young D Y, Bloch D A, McShane D J, Fries J F. Survival, prognosis, and causes of death in rheumatoid arthritis. Arthritis Rheum 1986; 29: 706–14
   PubMed Web of Science ®Google Scholar
• Pincus T, Callahan L F, Vaughn W K. Questionnaire, walking time and button test measures of functional capacity as predictive markers for mortality in rheumatoid arthritis. J Rheumatol 1987; 14: 240–51
   PubMed Web of Science ®Google Scholar
• Pincus T. Is mortality increased in rheumatoid arthritis (RA)?. J Musculoskel Med 1988; 5: 27–46
   Google Scholar
• Wright V. (Editorial) Questions on clinical trials. Br Med J 1983; 287: 569
   Google Scholar
• Kuhn T S. The Structure of Scientific Revolution, 2nd ed. University of Chicago Press. 1970
   Google Scholar
• Ropes M W, Bennett G A, Cobb S, Jacox R, Jessar R. 1958 Revision of diagnostic criteria for rheumatoid arthritis. Bull Rheum Dis 1958; 9: 175–6
   PubMedGoogle Scholar
• Arnett F, Edworthy S, Bloch D A, McShane D J, Fries J F, Cooper N S, Healey L A, Kaplan S R, Liang M H, Luthra H S, Medsger T A, Jr, Mitchell D M, Neustadt D H, Pinals R S, Schaller J G, Sharp J T, Wilder R L, Hunder G G. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
   PubMed Web of Science ®Google Scholar
• Kelley W N, Harris E D, Ruddy S, Sledge C B. Textbook of Rheumatology 1st ed. WB Saunders, Philadelphia 1981; 779
   Google Scholar
• When are corticosteroids worth the risk for rheumatoid arthritis patients?. J Musculoskel Med 1984; 1: 48–53
   Google Scholar
• Bailliere's Clinical Rheumatology. WB Saunders, London 1988; Vol. 2, No. 1
   Google Scholar
• O'Sullivan J B, Cathcart E S. The prevalence of RA: follow-up evaluation of the effect of criteria on rates in Sudbury Massachusetts. Ann Intern Med 1972; 76: 573–7
   PubMed Web of Science ®Google Scholar
• Mikkelson W M, Dodge H. A four year follow-up of suspected rheumatoid arthritis: the Tecumseh, Michigan, Community Health Study. Arthritis Rheum 1969; 12: 87–91
   PubMedGoogle Scholar
• Masi A T, Feigenbaum S L, Kaplan S B. Articular patterns in the early course of rheumatoid arthritis. Am J Med 1983; 75((Suppl. 6A))16–26
   PubMedGoogle Scholar
• Ragan C, Farington E. The clinical features of rheumatoid arthritis. JAMA 1962; 181: 663–7
   PubMed Web of Science ®Google Scholar
• Mikkelson W M, Dodge H J, Duff I F, Kato H. Estimates of the prevalence of rheumatic diseases in the population of Tecumseh, Michigan, 1959–1960. J Chron Dis 1967; 20: 351–69
   PubMedGoogle Scholar
• Adler E, Abramson J H, Elkan Z, Ben Hador S, Goldberg R. Rheumatoid arthritis in a Jerusalem population: 1. Epidemiology of the disease. Am J Epidemiol 1967; 85: 365–77
   PubMedGoogle Scholar
• Valkenberg H A, Ball J, Burch T A, Bennett P H, Lawrence J S. Rheumatoid factors in a rural population. Ann Rheum Dis 1966; 25: 497–507
   PubMedGoogle Scholar
• Burch T A, O'Brien W M, Lawrence J S, Bennett P H, Bunim J J. A comparison of the prevalence of rheumatoid arthritis and rheumatoid factor in Indian tribes living in Montana mountains and in Arizona desert. Arthritis Rheum 1963; 6: 765
   Google Scholar
• Baum J, Ziff M. Laboratory findings in rheumatoid arthritis. Arthritis and allied conditions, 10th ed., D J McCarty. Lea & Febiger, Philadelphia 1985; 643–59
   Google Scholar
• Carson D A. Rheumatoid Factor. Xextbook of Rheumatology, 2nd ed, W N Kelley, E D Harrow, S Ruddy, C B Sledge. WB Saunders, Philadelphia 1985; 664–76
   Google Scholar
• Pincus T. Rheumatoid arthritis: Disappointing long-term outcomes despite successful short-term clinical trials (Editorial). J Clin Epidemiol 1988; 41: 1037–41
   PubMed Web of Science ®Google Scholar
• Wolfe F, Hawley D J. Remission in rheumatoid arthritis. J Rheumatol 1985; 12: 245–52
   PubMed Web of Science ®Google Scholar
• Thompson P W, Kirwan J R, Bames C G. Practical results of treatment with disease-modifying anti-rheumatoid drugs. Br J Rheumatol 1985; 24: 167–75
   PubMedGoogle Scholar
• Amor B, Hereon D, Cherot A, Delbarre F. Polyarthrites rhumatoides evoluant depuis plus de 10 arts (1966–1978). Ann Med Interne. Paris 1981; 132: 168–73
   PubMedGoogle Scholar
• Situnayake R D, Grindulis K A, McConkey B. Long term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods. Ann Rheum Dis 1987; 46: 177–83
   PubMed Web of Science ®Google Scholar
• Feinstein A R. An additional basic science for clinical medicine: II. The limitations of randomized trials. Ann Intern Med 1983; 99: 544–50
   PubMed Web of Science ®Google Scholar
• Mitchell J M, Burkhauser R V, Pincus T. The importance of age, education and comorbidity in the substantial earnings losses of individuals with symmetric polyarthritis. Arthritis Rheum 1988; 31: 348–57
   PubMed Web of Science ®Google Scholar
• Allebeck P, Ahlbom A, Allander E. Increased mortality among persons with rheumatoid arthritis, but where RA does not appear on death certificate: Eleven years follow-up of on epidemiological study. Scand J Rheumatol 1981; 10: 301–6
   PubMed Web of Science ®Google Scholar
• Cobb S, Anderson F, Bauer W. Length of life and cause of death in rheumatoid arthritis. N Engl J Med 1953; 249: 553–6
   PubMed Web of Science ®Google Scholar
• Uddin J, Kraus A S, Kelly H G. Survivorship and death in rheumatoid arthritis. Arthritis Rheum 1970; 13: 125–30
   PubMed Web of Science ®Google Scholar
• Monson R R, Hall A P. Mortality among arthrittcs. J Chron Dis 1976; 29: 459–67
   PubMedGoogle Scholar
• Rasker J J, Cosh J A. Cause and age at death in a prospective stuay of 100 patients with rheummoid arthritis. Ann Rheum Dis 1981; 40: 115–20
   PubMed Web of Science ®Google Scholar
• Vandenbroucke J P, Hazevoet H M, Cats A. Survival and cause of death in rheumatoid arthritis: A 25-year prospective follow-up. J Rheumatol 1984; 11: 158–61
   PubMed Web of Science ®Google Scholar
• Mutru O, Laakso M, Isomaki H, Koota K. Ten-year mortality and causes of death in patients with rheumatoid arthritis. Br Med J 1985; 290: 1797–9
   PubMed Web of Science ®Google Scholar
• Vollertsen R S, Conn D L, Ballard D J, Ilstrup D M, Kazmar R E, Silverneld J C. Rhewnatoidfasculitis: Survival and associated risk factors. Medicine 1986; 65: 365–75
   PubMed Web of Science ®Google Scholar
• Duthie J JR, Brown P E, Iruelove L H, Baragar F D, Lawrie A J. Course and prognosis of rheumatoid arthritis: a further report. Ann Rheum Dis 1964; 23: 193–204
   PubMed Web of Science ®Google Scholar
• Rasker J J, Cosh J A. The natural history of'rheumatoid arthritis: a fifteen year follow-up study: The prognostic significance of features noted in thefirstyear. Clin Rheumatol 1981; 3: 11–20
   Google Scholar
• Gordon D A, Stein J L, Broder I. The extra-articular features of rheumatoid arthritis: A systematic analysis of 127 cases. Am J Med 1973; 54: 445–52
   PubMed Web of Science ®Google Scholar
• Proudfit W L, Bruschke A VG, Sones F M. Natural history of obstructive coronary artery disease: Ten-year study of 601 nonsurgical cases. Prog Cardiovasc Dis 1978; 21: 53–78
   PubMed Web of Science ®Google Scholar
• Kaplan H S. Survival as related to treatment. Hodman's Disease, H S. Kaplan. Harvard University Press, Cambridge, MA 1972; 360–88
   Google Scholar
• Bombardier C, Tugwell P, Sinclair A, Dok C, Anderson G, Buchanan W W. Preference for endpoint measures in clinical trials: results of structure workshops. J Rheumatol 1982; 9: 798–801
   PubMed Web of Science ®Google Scholar
• Weed L L. Medical records that guide and teach. N Engl M Med 1968; 278: 593–600; 652–7
   PubMed Web of Science ®Google Scholar
• The Research Sub-Committee of the Empire Rheumatism Council Gold therapy in rheumatoid arthritis–report of a multi-centre controlled trial. Ann Rheum Dis 1960; 19: 95–119
   PubMed Web of Science ®Google Scholar
• Fries J F, Spitz P, Kraines R G, Holman H R. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137–145
   PubMed Web of Science ®Google Scholar
• Meenan R F, Gertman P M, Mason J H. Measuring health status in arthritis: the Arthritis Impact Measurement Scales. Arthritis Rheum 1980; 23: 146–152
   PubMed Web of Science ®Google Scholar
• Pincus T, Summey J A, Soraci S A, Jr, Hummon N P, Wallston K A. Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 1983; 26: 1346–53
   PubMed Web of Science ®Google Scholar
• Feinstein A R, Josephy B R, Wells C K. Scientific and clinical problems in indexes of functional disability. Ann Intern Med 1986; 105: 413–20
   PubMed Web of Science ®Google Scholar
• Meenan R F, Pincus T. The status of patient status measures (editorial). J Rheumatol 1987; 14: 411–4
   PubMed Web of Science ®Google Scholar
• Meenan R F, Anderson J J, Kazis L E, Egger M J, Altz-Smith M, Samuelson C O, Jr, Willkens R F, Solsky M A, Hayes S P, Blocka K L, Weinstein A, Guttadauria M, Kaplan S B, Klippel J. Outcome assessment in clinical trials: evidence for the sensitivity of a health status measure. Arthritis Rheum 1984; 27: 1344–52
   PubMed Web of Science ®Google Scholar
• Bombardier C, Ware J, Russell D, Larson M, Chalmers A, Reed J L. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Am J Med 1986; 81: 565–78
   PubMed Web of Science ®Google Scholar
• Pincus T, Callahan L F, Brooks R, Fuchs H A, Olsen N J, Kaye J J. Self-report questionnaires are associated with physical, radiographic, and laboratory indicators ofclinical status in rheumatoid arthritis. Ann IntemMed 1989; 110: 259–66
   PubMed Web of Science ®Google Scholar
• Berkson J. Limitations of the application of fourfold table analysis to hospital data. Biomet Bull 1946; 2: 47–53
   PubMed Web of Science ®Google Scholar
• Pincus T, Callahan L F, Mitchell J M. Increased mortality in rheumatoid arthritis is explained in part on the basis of extensive comorbidity with other diseases. Arthritis Rheum 1987; 30(4)S12
   Google Scholar
• Pincus T, Callahan L F. Formal education as a marker for increased mortality and morbidity in rheumatoid arthritis. J Chron Dis 1985; 38: 973–84
   PubMedGoogle Scholar
• Callahan L F, Pincus T. Formal educational level as a significant marker of clinicalstatus in rheumatoid arthritis. Arthritis Rheum 1988; 31: 1346–57
   PubMed Web of Science ®Google Scholar
• Ruberman W, Weinblatt E, Goldberg J D, Chaudhaty B S. Psychosocial influences on mortality after myocardial infarction. N Engl J Med 1984; 311: 552–9
   PubMed Web of Science ®Google Scholar
• Marmot M G, Rose G, Shipley M, Hamilton P JS. Employment grade and coronary heart disease in British civil servants. J Epidemiol Community Health 1978; 32: 244–9
   PubMed Web of Science ®Google Scholar
• Pincus T, Callahan L F, Burkhauser R V. Most chronic diseases are reported more frequenuy by individuals with fewer than 12years of formal education in the age 18–64 United States population. J Chron Dis 1987; 40: 865–74
   PubMedGoogle Scholar
• LaVecchia C, Negri E, Pagano R, Decarli A. Education, prevalence of disease, and frequency of health care utilization. The 1983 Italian National Health Survey. J Epidemiol Community Health 1987; 41: 161–5
   PubMedGoogle Scholar
• Blaxter M. Evidence of inequality in health from a national survey. Lancet 1987; 30–3
   PubMedGoogle Scholar
• Marmot M G, McDowall M F. Mortality decline and widening social class inequalities. Lancet 1986; ii: 274–6
   Google Scholar
• Epstein A, Stem R S, Tbgnetti J, Begg C B, Hartley R M, Cumella E, Jr, Ayanian J Z. The association of patients' socioeconomic characteristics with the length of hospital slay and hospital charges within diagnosis-related groups. N Engl J Med 1988; 318: 1579–85
   PubMedGoogle Scholar
• Pincus T. Formal education level a marker for the importance of behavioral variables in the pathogenesis, morbidity and mortality of most diseases? (editorial). J Rheumatol 1988; 15: 1457–60
   PubMed Web of Science ®Google Scholar
• Nicassio P M, Wallston K A, Callahan L F, Herbert M A, Pincus T. The measurement of helplessness in rheumatoid arthritis: The development ofthe Arthritis Helplessness Index. J Rheumatol 1985; 12: 462–7
   PubMed Web of Science ®Google Scholar
• Callahan L F, Brooks R H, Pincus T. Further analysis of learned helplessness in rheumatoid arthritis using a “Rheumatology Attitudes Index”. J Rheumatol 1988; 15: 418–26
   PubMed Web of Science ®Google Scholar
• Lewis P, Hazleman B L, Hanka R, Roberts S. Cause of death inpatients with rheumatoid arthritis with particular reference to azathioprine. Ann Rheum Dis 1980; 39: 457–61
   PubMed Web of Science ®Google Scholar
• Prior P, Symmons D PM, Scott D L, Brown R, Hawkins C F. Cause of death in rheumatoid arthritis. Br J Rheumatol 1984; 23: 92–9
   PubMedGoogle Scholar